ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd

NCT06578286 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fudan University